Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 3
2013 2
2014 1
2016 3
2017 3
2020 3
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment.
Ademaj A, Veltsista DP, Ghadjar P, Marder D, Oberacker E, Ott OJ, Wust P, Puric E, Hälg RA, Rogers S, Bodis S, Fietkau R, Crezee H, Riesterer O. Ademaj A, et al. Among authors: halg ra. Cancers (Basel). 2022 Jan 26;14(3):625. doi: 10.3390/cancers14030625. Cancers (Basel). 2022. PMID: 35158893 Free PMC article. Review.
A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers.
Ademaj A, Veltsista PD, Marder D, Hälg RA, Puric E, Brunner TB, Crezee H, Gabrys D, Franckena M, Gani C, Horsman MR, Krempien R, Lindner LH, Maluta S, Notter M, Petzold G, Abdel-Rahman S, Richetti A, Thomsen AR, Tsoutsou P, Fietkau R, Ott OJ, Ghadjar P, Riesterer O. Ademaj A, et al. Among authors: halg ra. Strahlenther Onkol. 2023 May;199(5):436-444. doi: 10.1007/s00066-022-01980-9. Epub 2022 Aug 29. Strahlenther Onkol. 2023. PMID: 36038671 Free PMC article.
Tetramodal therapy with transurethral resection followed by chemoradiation in combination with hyperthermia for muscle-invasive bladder cancer: early results of a multicenter phase IIB study.
Riesterer O, Ademaj A, Puric E, Eberle B, Beck M, Gomez S, Marder D, Oberacker E, Rogers S, Hälg RA, Kern T, Schwenne S, Stein J, Stutz E, Timm O, Zschaeck S, Weyland MS, Veltsista PD, Wyler S, Wust P, Scheidegger S, Bodis S, Ghadjar P. Riesterer O, et al. Among authors: halg ra. Int J Hyperthermia. 2022;39(1):1078-1087. doi: 10.1080/02656736.2022.2109763. Int J Hyperthermia. 2022. PMID: 35993234 Free article. Clinical Trial.
20 results